Nuwellis, Inc.

US$4.58As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:NUWEHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (93.25%)
Div yield —
ROE —
Medical Devices
Beta (5Y) 0.02
PE TTM —
TSR TTM (99.49%)
Mkt cap US$1.856M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$5.50
20.14%
(34.35%)
Hold 10|5|11|11|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.04
0.05
0.05
0.04
1.83%
1.48%
4.76%
0.17%
Revenue$M
0.143
0.145
0.151
0.155
(1.20%)
1.54%
0.47%
5.95%
Peers (US$1.856M)
Cap (US$)
PE
2.126M
—
Capital
TTM
5Y
10Y
Leveragex
1.429
1.328
1.058
EBIT/Intx
10.52
0.425
0.379
Own earn%
(90.24)
(21.20)
(19.50)
Sh yield%
39.49
50.92
55.15
Owners
Insiders/Inst%
13.99
21.23
Short interest%
0.97
SBC / revenue%
1.09
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
19–25
$1 testx
—
Incr. ROIC%
10